期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

恶性胸腔积液的诊断及治疗进展 被引量：4

原文传递
导出
摘要 恶性胸腔积液（Malignant pleural effusions,MPEs）由胸膜原发恶性肿瘤或胸膜腔内外恶性肿瘤通过血行、淋巴转移及直接种植至胸膜所引起的胸腔积液.根据2009年国际抗癌联盟（UICC）制定的最新肺癌分期标准,分期为M1a期[1],为晚期肺癌的重要标志.MPEs不易控制,积液量不断增多易并发肺不张和反复感染,常造成严重的呼吸困难和循环障碍.因此,如何早期发现MPEs,采取有效措施控制胸腔积液,缓解呼吸困难,提高生活质量,延长生命,成为治疗的关键.本文结合文献对MPEs的诊断及治疗进展作一综述.
作者 冯兴（综述） 李浒（审校）
机构地区 杭州市第一人民医院胸外科南京医科大学附属杭州医院
出处 《中国医师杂志》 CAS 2011年第12期1714-1717,共4页 Journal of Chinese Physician
基金 基金项目：杭州市医药卫生科技计划项目（20088008） 杭州市科技发展计划项目（20090833803）
关键词 胸腔积液 恶性/诊断/治疗 综述
分类号 R561.3 [医药卫生—呼吸系统]
  • 相关文献

参考文献27

  • 1Detterbeck FC ,Boffa DJ,Tanoue LT. The new lung cancer staging system. Chest,2009,136 ( 1 ) :260-271.
  • 2Lee YC, Light RW, Musk AW. Management of malignant pleural mesothelioma: a critical review. CUlT Opin Pulm Med, 2000,6 (4) :267-274.
  • 3Heffner JE, Klein JS, Hampson C. Diagnostic utility and clinical application of imaging for pleural space infections. Chest, 2010, 137(2) :467-479.
  • 4Mayo PH, Doelken P. Pleural uhrasonography. Clin Chest Med, 2006,7 (2) :215-227.
  • 5Yilmaz U, Polar G, Sahin N, et al. CT in differential diagnosis of benign and malignant pleural disease. Monaldi Arch Chest Dis, 2005,63( 1 ) :17-22.
  • 6Chakrabarti B, Ryland I, Sheard J, et al. The role of Abrams percutaneous pleural biopsy in the investigation of exudative pleural effusions. Chest ,2006,129 (6) : 1549-1555.
  • 7John E, Jeffrey S. Recent advances in the diagnosis and management of malignant pleural effusions. Mayo Clin Proc, 2008,83 (2) :235-250.
  • 8Benlloch S, Galbis-Caravajal JM, Martin C, etal. Potential diagnostic value of methylation profile in pleural fluid and serum from cancer patients with pleural effusion. Cancer, 2006, 107 ( 8 ) : 1859-1865.
  • 9Northup JK, Gadre SA, Ge Y, et al. Do cytogenetie abnormalities precede morphologic abnormalities in a developing malignant condition? Eur J Haematol,2007,78(2) :152-156.
  • 10Ferret J, Roldan J, Teixidor J, et al. Predictors of pleural malignancy in patients with pleural effusion undergoing thoracoscopy. Chest ,2005,127 ( 3 ) : 1017-1022.

二级参考文献27

  • 1李振 许德顺.恶性肿瘤的化学治疗与免疫治疗[M].北京:人民卫生出版社,1993.63.
  • 2小川健治.关于实行香菇多糖肿瘤局部投药的探讨[J].癌与化学疗法,1994,21(13):2101-2101.
  • 3[2]Skaguchi Y, Stephenslc. Apoptosis in tumors anal normal tissues induced by whole body byperthermia in rats [ J]. Cancer Res, 1995;55:5459- 60
  • 4[4]Eikesdal HP, Bjerkvig R, Dahl O. Vinblastine and hyperthermia target the neovasculature in BT(4)AN rat gliomas: therapeutic implicatious of the vascular phenotype [ J ]. Int J Radiat Oncol Biol Phys, 2001; 51(2):535-7
  • 5李鼎九 胡自省.肿瘤热疗学[M](第2版)[M].郑州:河南医科大学出版社,2002.1-20.
  • 6Fa1k MH, Isse1s RD. Hyperthermia in onco1ogy [J].Int J Hyperthermia, 2001,17(1):1-18.
  • 7Pass HI.Malignant pleural and pericardial effusions[A].DeVita VT,Hellman S,Rosenberg SA.Cancer:Principles and Practice of Oncology[M].5th ed,Philadelphia:Lippincott-Raven Publishers,1997:2586-2598.
  • 8Fenton KN,Richardson JD.Diagnosis and management of malignant pleural effusions[J].Am J Surg,1995,170(1):69-74.
  • 9Sugiura S,Ando Y,Minami H,et al.Prognostic value of pleural effusion in patients with non-small cell lung cancer.Clin Cancer Res,1997,3(1):47-50.
  • 10Shigemura N,Akashi A,Nakagiri T,et al.Pleural perfusion thermo-chemotherapy under VATS:a new less invasive modality for advanced lung cancer with pleural spread.Ann Thorac Surg,2004,77(3):1016-1022.

共引文献50

同被引文献40

  • 1孔令兴.注射用甘露聚糖肽治疗恶性胸腔积液效果观察[J].中国乡村医药,2007,14(3):10-11. 被引量：9
  • 2杨学宁 吴一龙.WHO肿瘤病灶分类及疗效评价、抗癌药物的毒性.肺癌多学科综合治疗的理论与实践[M].北京:人民卫生出版社,2000.390-394.
  • 3Bielsa S, Martin-Juan J, Porcel JM, et al. Diagnostic and prognostic implications of pleural adhesions in malignant effusions [J]. J Tho- rac Onco1,2008,3 ( 11 ) : 1251 - 1256.
  • 4孙燕,顾慰萍.癌症三阶梯止痛指导原则.2版.北京:北京医科大学出版社,2009:1.110.
  • 5黄燕琴,吴燕蓉,吴云.应用中心静脉导管引流胸腔积液的观察及护理.中国医药,2011,6(z1):60-61.
  • 6徐晓峰,沈鹰.复方苦参注射液联合顺铂治疗34例恶性胸腔积液临床分析.中国医师进修杂志,2011,34(12):56-57.
  • 7Dere K, Sucullu I, Budak ET, et al. A comparison of dexmedeto- midine versus midazolam for sedation, pain and hemodynamic con- trol, during eolonoseopy under conscious sedation [ J ]. Eur J An- aesthesiol, 2010, 27 (7): 648-652. DOI: 10. 1097/EJA. 0b013e3283347bfe.
  • 8Wijeysundera DN, Bender JS, Beattie WS. Alpha-2 adrenergic agonists for the prevention of cardiac complications among patients undergoing surgery [ J ]. Cochrane Database Syst Rev, 2009, (4) :CD004126. DOI: 10. 1002/14651858. CD004126. pub2.
  • 9Kang WS, Kim SY, Son JC, et al. The effect of dexmedetomidine on the adjuvant propofol requirement and intraoperative hemody- namics during remifentanil-based anesthesia [ J ]. Korean J Anes- thesol, 2012,62(2) : 113-118. DOI: 10. 4097/kjae. 2012.62. 2. 113.
  • 10Mizrak A, Koruk S, Bilgi M, et al. Pretreatment with dexmedeto- midine or thiopental decreases myoclonus after etomidate: a ran- domized, double-blind controlled trial[ J]. J Surg Res, 2010,159 (1) :ell-el6. DOI: 10. 1016/j. jss. 2009. 07. 031.

引证文献4

二级引证文献16

中国医师杂志
2011年 第12期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部